Fintel reports that on February 20, 2026, B of A Securities upgraded their outlook for Tandem Diabetes Care (NasdaqGM:TNDM) from Underperform to Neutral.
Analyst Price Forecast Suggests 34.43% Upside
As of February 4, 2026, the average one-year price target for Tandem Diabetes Care is $24.90/share. The forecasts range from a low of $14.14 to a high of $57.75. The average price target represents an increase of 34.43% from its latest reported closing price of $18.52 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Tandem Diabetes Care is 1,133MM, an increase of 12.51%. The projected annual non-GAAP EPS is 0.01.
What is the Fund Sentiment?
There are 456 funds or institutions reporting positions in Tandem Diabetes Care. This is an decrease of 53 owner(s) or 10.41% in the last quarter. Average portfolio weight of all funds dedicated to TNDM is 0.10%, an increase of 4.36%. Total shares owned by institutions decreased in the last three months by 2.22% to 90,349K shares. 
The put/call ratio of TNDM is 0.41, indicating a bullish outlook.
What are Other Shareholders Doing?
Sessa Capital IM holds 5,000K shares representing 7.37% ownership of the company. No change in the last quarter.
IJR - iShares Core S&P Small-Cap ETF holds 3,968K shares representing 5.85% ownership of the company. In its prior filing, the firm reported owning 4,058K shares , representing a decrease of 2.28%. The firm decreased its portfolio allocation in TNDM by 5.69% over the last quarter.
ArrowMark Colorado Holdings holds 2,890K shares representing 4.26% ownership of the company. In its prior filing, the firm reported owning 3,691K shares , representing a decrease of 27.74%. The firm increased its portfolio allocation in TNDM by 67.95% over the last quarter.
GW&K Investment Management holds 2,675K shares representing 3.95% ownership of the company. No change in the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,150K shares representing 3.17% ownership of the company. In its prior filing, the firm reported owning 2,072K shares , representing an increase of 3.59%. The firm decreased its portfolio allocation in TNDM by 9.97% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
